About Miles Harrison
Miles Harrison is a president and CEO, director at Conexeu Sciences.
Form D filings also name Miles Harrison as a chief executive officer at Novaestiq and sits on its board.
Miles Harrison first appears on SEC filings in 2021.
Experience
This experience comes from Miles Harrison's profile and from SEC filings. For roles taken from filings, the years are when the filings name Miles Harrison in the role, so the role may have started earlier or lasted longer.
Conexeu Sciences Inc. Current
President & Chief Executive Officer (2025 – Present)
Director
2025 – Present · Reno, NV
Develops an investigational tissue-restoration device for wound care and other medical uses.
CI
Castle Biosciences, Inc. Current
Board Member
2020 – Present
Novaestiq Corp.
Co-Founder, President & Chief Executive Officer (2021 – 2025)
Director
2021 – 2025 · Southlake, TX
GA
Galderma
President & General Manager, North America
2014 – 2021
BL
Brand Maximization LLC
President / Owner
2014
NA
Novartis Pharmaceuticals AG
VP & Head Global Advocacy
2012 – 2014
NO
Novartis Oncology
VP & Head Global Brand Maximization
2009 – 2012
NH
Novartis Consumer Health
SVP & Region Head LATAM
1997 – 2009
Key Colleagues at Startups
The people Miles Harrison works with at each company, as listed on that company's latest Form D.
Conexeu Sciences Inc. · Form D, Nov 5, 2026
David Bogart
Chief Commercial Officer, Co-Founder & Director
AF
Aaron Farberg
Director
SI
Claudia Chavez-Munoz
Chief Scientific Officer, Co-Founder
Jeff Sharpe
Chairman
ZL
Z Lorenc
Plastic Surgeon and director
SP
Sebastian Purcell
Director
Brian Pilcher
Chief Medical Officer
AC
Andrew Costa
Director
AB
April Burke
Director
AP
Ana Bastiani-Posner
Director
Novaestiq Corp. · Form D/A, Apr 17, 2024
HA
Humberto Antunes
Executive officer and director
ER
Ethan Rigel
Executive officer